Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33604137)
Watch
English
Bicalutamide dosages used in the treatment of prostate cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
Bicalutamide dosages used in the treatment of prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
main subject
bicalutamide
1 reference
based on heuristic
inferred from title
prostate cancer
1 reference
based on heuristic
inferred from title
author name string
Kolvenbag GJ
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
Nash A
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
publication date
1 April 1999
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
published in
The Prostate
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
volume
39
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
issue
1
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
page(s)
47-53
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
cites work
Casodex (ICI 176,334), a new, non-steroidal anti-androgen. Early clinical results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Relative potencies of flutamide and 'Casodex'
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Evaluation of a peripherally selective antiandrogen (Casodex) as a tool for studying the relationship between testosterone and spermatogenesis in the rat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
The preclinical development of bicalutamide: pharmacodynamics and mechanism of action
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Flutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Pharmacodynamics and pharmacokinetics of bicalutamide: defining an active dosing regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Worldwide activity and safety of bicalutamide: a summary review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Randomised study of Casodex 50 MG monotherapy vs orchidectomy in the treatment of metastatic prostate cancer. The Scandinavian Casodex Cooperative Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Relative potencies of Flutamide and Casodex: preclinical studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
The pharmacokinetics of Casodex in laboratory animals
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic Carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C47%3A%3AAID-PROS8%3E3.0.CO%3B2-X
retrieved
21 January 2018
Identifiers
DOI
10.1002/(SICI)1097-0045(19990401)39:1<47::AID-PROS8>3.0.CO;2-X
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
PubMed ID
10221266
1 reference
stated in
Europe PubMed Central
PubMed ID
10221266
retrieved
28 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
